The Ruesch Center

The Ruesch Center and Medscape collaborate to cover topics essential to the practicing clinician who has an interest in gastrointestinal cancers -- by providing information on emerging treatments, practice standards, and individualized patient care.

Latest Features from The Ruesch Center

Why the High CRC Rate in Latino--Genes, Stigma, or Other Factors? Colorectal cancer is the second most common cause of cancer death in the Latino population. Drs John Marshall and Marcia Cruz-Correa discuss which factors are at play.
Ruesch Center, March 20, 2017
Colorectal Cancer in Young Adults: An 'Issue Screaming for Action' Dr John Marshall speaks to Dr Thomas Weber about the increasing incidence of colorectal cancer in young adults and simple steps that clinicians can take to slow this disturbing trend.
Ruesch Center, January 30, 2017
Oncology and Politics: How Long Will the Honeymoon Last? A commentary on Joe Biden's Moonshot address at ASCO and what it will really take to make the initiative successful.
Ruesch Center, June 27, 2016
Tumor 'Profiling' Takes on New Significance in GI Cancer Dr Brandon Smaglo reviews key GI cancer presentations from ASCO 2016, finding that growing refinement of tumor subtyping is key to matching patients with effective treatments, including immunotherapy.
Ruesch Center, June 14, 2016
'Releasing the Dogs’ in the Body’s War on Cancer Drs Lou Weiner and Chris Heery vividly describe strategies that prompt the immune system to attack and kill cancer cells, and offer a view from the trenches of cancer immunotherapy.
Ruesch Center, February 18, 2016

Taking a Break From the Medical 'Service Industry' John Marshall discusses his excitement and apprehension for his upcoming sabbatical.
Medscape Oncology, June 2019
Molecular Profiling Is Key to GI Cancer Treatment Success John Marshall reports on treatment trials in gastric, pancreatic, and colon cancers, from the 2019 GI Cancers Symposium.
Medscape Oncology, February 2019
Hype, Fear of Failure Driving Immunotherapy 'Hail Mary' Treatments John Marshall speaks with Leonard Saltz and Tanios Bekaii-Saab about the destructive trend of trying experimental drugs before having the data, and the new 'right to try' law.
Medscape Oncology, June 2018

About The Ruesch Center

The Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi combines expertise in molecular medicine, translational research, and a patient-centered philosophy, the Ruesch Center will realize the dream of individualized curative therapies through research, care, and advocacy.